These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2858443)

  • 21. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cellular immune response to myelin basic proteins in patients with dilated cardiomyopathy].
    Aleksandrova LZ; Bakhov NI; Titov VN; Gervazieva VB; Naumov VG
    Ter Arkh; 1987; 59(12):51-7. PubMed ID: 2451862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation between helper and suppressive/cytotoxic T lymphocytes in the peripheral blood in patients with dilated cardiomyopathy].
    Smalcelj A; Duraković Z; Batinić D; Bogdan I; Grgić V
    Acta Med Iugosl; 1991; 45(1):3-13. PubMed ID: 1827936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune myocarditis: cellular mediators of cardiac dysfunction.
    Afanasyeva M; Georgakopoulos D; Rose NR
    Autoimmun Rev; 2004 Nov; 3(7-8):476-86. PubMed ID: 15546794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody.
    Gong X; Feng H; Zhang S; Yu Y; Li J; Wang J; Guo B
    J Mol Cell Cardiol; 2007 Apr; 42(4):781-91. PubMed ID: 17362985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some T-cell functions in patients with viral myocarditis. The effect of levamisole.
    Goch JH; Czernicki J; Offierska M
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):395-404. PubMed ID: 6223612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated immune cardiocyte injury in viral myocarditis of mice and patients.
    Deguchi H; Kitaura Y; Hayashi T; Kotaka M; Kawamura K
    Jpn Circ J; 1989 Jan; 53(1):61-77. PubMed ID: 2541265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis. Their similarity to extrathymic T cells in mice and the site of proliferation.
    Hanawa H; Tsuchida M; Matsumoto Y; Watanabe H; Abo T; Sekikawa H; Kodama M; Zhang S; Izumi T; Shibata A
    J Immunol; 1993 Jun; 150(12):5682-95. PubMed ID: 8515083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells.
    Pummerer CL; Grässl G; Sailer M; Bachmaier KW; Penninger JM; Neu N
    Lab Invest; 1996 May; 74(5):845-52. PubMed ID: 8642780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy.
    Maisch B
    Basic Res Cardiol; 1986; 81 Suppl 1():217-41. PubMed ID: 2947566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peripheral T-lymphocyte subpopulations in primary and alcoholic dilated cardiomyopathy].
    Sachs RN; Hatron PY; Saizy C; Lanfranchi J
    Ann Med Interne (Paris); 1985; 136(3):229-32. PubMed ID: 3161445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D; Rose NR
    Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The viral and immunological characteristics of cardiomyopathies and myocarditis].
    Moiseev VS; Ogurtsov PP; Traianova TG; Savinov AP; Lavrova IK; Stepina VN; Shelepin AA; Rukosuev VS; Tereshchenko SE; Korovina EA
    Ter Arkh; 1990; 62(8):77-82. PubMed ID: 2274878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
    Huber SA; Lyden DC; Lodge PA
    Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune myocarditis: past, present and future.
    Leuschner F; Katus HA; Kaya Z
    J Autoimmun; 2009; 33(3-4):282-9. PubMed ID: 19679447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some T-cell functions in patients with viral myocarditis. The effect of polymorphonuclear leukocyte (PMNL) lysosome factors on T-suppressor cell activity in vitro.
    Czernicki J; Goch JH
    Arch Immunol Ther Exp (Warsz); 1983; 31(1):51-6. PubMed ID: 6225406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of T-lymphocytes in organ-specific autoimmune diseases].
    Fierz W
    Schweiz Med Wochenschr; 1987 Mar; 117(11):391-8. PubMed ID: 3495035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.